Ensysce Biosciences regains compliance with Nasdaq listing rule, shares rise

Ensysce Biosciences

14/06/2023 18:35

** Shares of drug developer Ensysce Biosciences  ENSC.O  up
as much as 4.3% at $2.42 
    ** Says on June 13, co was notified by Nasdaq it has
regained compliance with equity requirement in listing rule 
    ** In Jan, co received notice in form of deficiency letter
from Nasdaq
    ** Co had until July 26 to regain compliance 
    ** Including session's gain, stock has plunged ~73% YTD 

 (Reporting by Amna Karimi in Bengaluru)
 ((Amna.Karimi@thomsonreuters.com; +91 8083261226;))